Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery
Authors
Keywords
-
Journal
Nanomedicine
Volume 10, Issue 13, Pages 2093-2107
Publisher
Future Medicine Ltd
Online
2015-06-22
DOI
10.2217/nnm.15.47
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Topically Administered Gold Nanoparticles Inhibit Experimental Corneal Neovascularization in Mice
- (2015) Won-Kyung Cho et al. CORNEA
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
- (2014) Robert L Avery et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal drug delivery in retinal disease: are we out of our depth?
- (2014) Sachin S Thakur et al. Expert Opinion on Drug Delivery
- Nanoparticle-Assisted Targeted Delivery of Eye-Specific Genes to Eyes Significantly Improves the Vision of Blind Mice In Vivo
- (2014) Ammaji Rajala et al. NANO LETTERS
- Diabetic macular edema: new concepts in patho-physiology and treatment
- (2014) Xinyuan Zhang et al. Cell and Bioscience
- Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
- (2013) Ling Luo et al. ACS Nano
- Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide
- (2013) Ron B. Shmueli et al. BIOMATERIALS
- Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration
- (2013) Xiying Wang et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells
- (2013) Maqusood Ahamed HUMAN & EXPERIMENTAL TOXICOLOGY
- Sustained delivery of a HIF-1 antagonist for ocular neovascularization
- (2013) Takeshi Iwase et al. JOURNAL OF CONTROLLED RELEASE
- Ocular neovascularization
- (2013) Peter A. Campochiaro JOURNAL OF MOLECULAR MEDICINE-JMM
- Treatment of age-related macular degeneration
- (2013) Chui Ming Gemmy Cheung et al. LANCET
- Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
- (2013) Uday B. Kompella et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Hybrid Dendrimer Hydrogel/PLGA Nanoparticle Platform Sustains Drug Delivery for One Week and Antiglaucoma Effects for Four Days Following One-Time Topical Administration
- (2012) Hu Yang et al. ACS Nano
- Flt1 peptide–hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization
- (2012) Hyemin Kim et al. Acta Biomaterialia
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Focused Magnetic Stem Cell Targeting to the Retina Using Superparamagnetic Iron Oxide Nanoparticles
- (2012) Anat Yanai et al. CELL TRANSPLANTATION
- Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers
- (2012) Li Gan et al. DRUG DISCOVERY TODAY
- Novel micelle carriers for cyclosporin A topical ocular delivery: In vivo cornea penetration, ocular distribution and efficacy studies
- (2012) Claudia Di Tommaso et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Age-related macular degeneration
- (2012) Laurence S Lim et al. LANCET
- Diclofenac/biodegradable polymer micelles for ocular applications
- (2012) Xingyi Li et al. Nanoscale
- Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
- (2012) Joan W. Miller et al. OPHTHALMOLOGY
- Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor
- (2011) Dong Hyun Jo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Gene Transfer Using Micellar Nanovectors Inhibits Choroidal Neovascularization In Vivo
- (2011) Aya Iriyama et al. PLoS One
- The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation
- (2010) Jin Hyoung Kim et al. BIOMATERIALS
- Blood-Retinal Barrier
- (2010) José Cunha-Vaz et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Silver nano — A trove for retinal therapies
- (2010) Kalimuthu Kalishwaralal et al. JOURNAL OF CONTROLLED RELEASE
- Emerging therapeutic approaches in the management of retinal angiogenesis and edema
- (2010) An Truong et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Impacts of Mesoporous Silica Nanoparticle Size, Pore Ordering, and Pore Integrity on Hemolytic Activity
- (2010) Yu-Shen Lin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Diabetic retinopathy
- (2010) Ning Cheung et al. LANCET
- Smaller Birth Size is Associated With Narrower Retinal Arterioles in Early Adolescence
- (2010) BAMINI GOPINATH et al. MICROCIRCULATION
- Retinal-Vein Occlusion
- (2010) Tien Y. Wong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
- (2010) Juan L. Vivero-Escoto et al. Small
- Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases
- (2010) Namdev B. Shelke et al. Drug Delivery and Translational Research
- Antiangiogenic properties of silver nanoparticles
- (2009) Sangiliyandi Gurunathan et al. BIOMATERIALS
- Dual-drug delivery system based on hydrogel/micelle composites
- (2009) Lan Wei et al. BIOMATERIALS
- Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells
- (2009) Kalimuthu Kalishwaralal et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nanocarriers in Ocular Drug Delivery: An Update Review
- (2009) Sheetu Wadhwa et al. CURRENT PHARMACEUTICAL DESIGN
- Nanoparticle-Mediated Expression of an Angiogenic Inhibitor Ameliorates Ischemia-Induced Retinal Neovascularization and Diabetes-Induced Retinal Vascular Leakage
- (2009) K. Park et al. DIABETES
- Overcoming the barriers in micellar drug delivery: loading efficiency,in vivostability, and micelle–cell interaction
- (2009) Sungwon Kim et al. Expert Opinion on Drug Delivery
- Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV
- (2009) S R Singh et al. GENE THERAPY
- Intravenously administered gold nanoparticles pass through the blood–retinal barrier depending on the particle size, and induce no retinal toxicity
- (2009) Jeong Hun Kim et al. NANOTECHNOLOGY
- Vitreous Levels of Erythropoietin and Vascular Endothelial Growth Factor in Eyes with Retinopathy of Prematurity
- (2009) Tatsuhiko Sato et al. OPHTHALMOLOGY
- SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB
- (2009) IOANNIS D. LADAS et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆
- (2008) I SLOWING et al. ADVANCED DRUG DELIVERY REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started